![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 28, 2004 11:04:53 PM
So if I'm not mistaken, we are about to go from a company that was near bankrupt a year and a half ago, to owning a 52+-% stake in a $26 Million Bio Pharma Company ($51 Million if you add DNAPrint's investment according to the PR).
JMHO...if this is one of the steps Dr. Frudakis referred to last summer, and he also said that they needed to escape the OTC, restructure their shares, do it in a way that didn't alienate existing shareholders, and couple the whole thing with their graduation to becoming a Pharma company, seems like the stage is set for a merger and recapitalization at some point.
I know everyone thinks of reverse split when they think of restructuring, but IMO, and MO ONLY, merger and recap makes more sense given today's developments.
Should be interesting to watch though...I HOPE! LOL
Later,
W2P
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM